These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3160034)

  • 41. Is it necessary to perform urine cytology in screening patients with haematuria?
    Chahal R; Gogoi NK; Sundaram SK
    Eur Urol; 2001 Mar; 39(3):283-6. PubMed ID: 11275720
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes of a bladder cancer screening program using home hematuria testing and molecular markers.
    Bangma CH; Loeb S; Busstra M; Zhu X; El Bouazzaoui S; Refos J; Van Der Keur KA; Tjin S; Franken CG; van Leenders GJ; Zwarthoff EC; Roobol MJ
    Eur Urol; 2013 Jul; 64(1):41-7. PubMed ID: 23478169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Asymptomatic microscopic hematuria as a predictor of neoplasia in the urinary tract.
    Ordell Sundelin M; Jensen JB
    Scand J Urol; 2017 Oct; 51(5):373-375. PubMed ID: 28644736
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of i.v. urography in patients with haematuria.
    Mishra VC; Rowe E; Rao AR; Laniado ME; Motiwala HG; Hudd C; Karim OM
    Scand J Urol Nephrol; 2004; 38(3):236-9. PubMed ID: 15204378
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Half of visible and half of recurrent visible hematuria cases have underlying pathology: prospective large cohort study with long-term followup.
    Mishriki SF; Vint R; Somani BK
    J Urol; 2012 May; 187(5):1561-5. PubMed ID: 22425074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Practical use of investigations in patients with hematuria.
    El-Galley R; Abo-Kamil R; Burns JR; Phillips J; Kolettis PN
    J Endourol; 2008 Jan; 22(1):51-6. PubMed ID: 18315474
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria.
    Sarosdy MF; Kahn PR; Ziffer MD; Love WR; Barkin J; Abara EO; Jansz K; Bridge JA; Johansson SL; Persons DL; Gibson JS
    J Urol; 2006 Jul; 176(1):44-7. PubMed ID: 16753364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microscopic haematuria: urological investigation using a standard protocol.
    Sultana SR; Goodman CM; Byrne DJ; Baxby K
    Br J Urol; 1996 Nov; 78(5):691-6; discussion 697-8. PubMed ID: 8976762
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Asymptomatic microscopic hematuria in women: case series and brief review.
    Singh GS; Rigsby DC
    Int Urogynecol J Pelvic Floor Dysfunct; 1999; 10(6):361-4. PubMed ID: 10614970
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment and clinical significance of haematuria in Malaysian patients - relevance to early cancer diagnosis.
    Ng KL; Htun TH; Dublin N; Ong TA; Razack AH
    Asian Pac J Cancer Prev; 2012; 13(6):2515-8. PubMed ID: 22938414
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Critical study of microscopic hematuria disclosed by screening tests].
    Giudicelli CP; Larroque P; Nedelec G; Talarmin F; Castanet F
    Ann Med Interne (Paris); 1984; 135(7):557-60. PubMed ID: 6393833
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The significance of asymptomatic microhematuria in women and its economic implications. A ten-year study.
    Bard RH
    Arch Intern Med; 1988 Dec; 148(12):2629-32. PubMed ID: 3196125
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Urinary tract ultrasonography in the evaluation of haematuria--a report of over 1,000 cases.
    Datta SN; Allen GM; Evans R; Vaughton KC; Lucas MG
    Ann R Coll Surg Engl; 2002 May; 84(3):203-5. PubMed ID: 12092877
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Haematuria clinic--a preliminary audit and considerations for a one-stop assessment centre.
    Tan PK; Chang HC; Sitoh YY
    Singapore Med J; 1998 Nov; 39(11):501-3. PubMed ID: 10067387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multidetector computerized tomography urography as the primary imaging modality for detecting urinary tract neoplasms in patients with asymptomatic hematuria.
    Sudakoff GS; Dunn DP; Guralnick ML; Hellman RS; Eastwood D; See WA
    J Urol; 2008 Mar; 179(3):862-7; discussion 867. PubMed ID: 18221955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Can hematuria be a predictor as well as a symptom or sign of bladder cancer?
    Friedman GD; Carroll PR; Cattolica EV; Hiatt RA
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):993-6. PubMed ID: 8959322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term outcome of patients with a negative work-up for asymptomatic microhematuria.
    Madeb R; Golijanin D; Knopf J; Davis M; Feng C; Fender A; Stephenson L; Messing EM
    Urology; 2010 Jan; 75(1):20-5. PubMed ID: 19913883
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Should the presence of a culture positive urinary tract infection exclude patients from rapid evaluation hematuria protocols?
    Vasdev N; Thorpe AC
    Urol Oncol; 2013 Aug; 31(6):909-13. PubMed ID: 21917488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-risk patients with hematuria are not evaluated according to guideline recommendations.
    Elias K; Svatek RS; Gupta S; Ho R; Lotan Y
    Cancer; 2010 Jun; 116(12):2954-9. PubMed ID: 20564400
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Etiology of asymptomatic microscopic hematuria in adults.
    Yamamoto M; Hibi H; Miyake K
    Hinyokika Kiyo; 1993 May; 39(5):413-7. PubMed ID: 8322622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.